Weight Loss
Ozempic®
A once-weekly semaglutide injection, FDA-approved for type 2 diabetes, with cardiovascular and kidney-protective benefits in eligible adults.
Price is based on patient insurance and pharmacy collection
*Requires a Mochi Health Membership. Cost of medication not included in Mochi Health Membership Fee
Results
Treatment overview
FDA-Approved for Type 2 Diabetes
1
Ozempic is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Cardiovascular Risk Reduction
2
FDA-approved to reduce the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease.
Kidney & CV Protection
3
FDA-approved to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
Proven A1C Reduction
4
Clinical trials demonstrated meaningful reductions in HbA1c across multiple dose levels.
Once-Weekly Injection
5
A simple subcutaneous injection taken once a week, on the same day each week, with or without food.
Pre-filled Multi-Dose Pen
6
Comes in a pre-filled pen designed for straightforward self-administration.
The treatment
Understanding the treatment
Active Ingredient:
Semaglutide
Ozempic is a once-weekly injectable GLP-1 receptor agonist containing semaglutide. It is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes; to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; and to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. Semaglutide enhances glucose-dependent insulin secretion, suppresses glucagon when glucose is elevated, slows gastric emptying, and reduces appetite. Dosing is titrated gradually upward to minimize gastrointestinal side effects.
Side effects
Most common: nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, injection-site reactions. Less common but serious: pancreatitis, gallbladder disease, kidney injury, hypoglycemia (with other diabetes meds), diabetic retinopathy progression, and rare allergic reactions.
Avoid When
Personal or family history of medullary thyroid cancer or MEN 2; history of pancreatitis; severe GI disease including gastroparesis; pregnancy or breastfeeding; known hypersensitivity. Caution with insulin/sulfonylureas, gallbladder disease, diabetic retinopathy, and significant kidney disease.
Personalized care
The medication is
the smaller part
Mochi pairs you with a physician, care team, pharmacist, and personalized plan designed to support your body, progress, and long-term goals over time.
For iOS & Android
